SCHEMBL493203

SCHEMBL493203

O=C(COC1CCCN(S(=O)(=O)c2c(Cl)cc(Cl)cc2Cl)C1)NCC1CCC(C(c2ccccc2)N2CCCC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.37
ACHE P22303 7/20 0.37
BCHE P06276 5/20 0.37
TDP1 Q9NUW8 2/20 0.35
DPP4 P27487 1/20 0.35
CACNA2D1 P54289 2/20 0.34
CACNA1B Q00975 2/20 0.34
CACNB1 Q02641 2/20 0.34
CACNA1C Q13936 2/20 0.34
LMNA P02545 1/20 0.34
ACLY P53396 1/20 0.34
KMT2A Q03164 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34
EPHX2 P34913 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492870 0.96 FAAH (0.38) FAAHACHEBCHETDP1CACNA2D1
SCHEMBL493619 0.94 KMT2A (0.37) FAAHACHEBCHETDP1DPP4
SCHEMBL493584 0.90 LMNA (0.38) FAAHACHEBCHETDP1CACNA2D1
SCHEMBL493261 0.90 PTGIR (0.38) FAAHACHEBCHETDP1DPP4
SCHEMBL492834 0.89 SMN1; SMN2 (0.42) TDP1DPP4CACNA2D1CACNA1BCACNB1
SCHEMBL493302 0.88 FAAH (0.39) FAAHACHEBCHETDP1LMNA
SCHEMBL493465 0.88 KMT2A (0.37) FAAHACHEBCHEDPP4LMNA
SCHEMBL493327 0.86 EPHX2 (0.39) FAAHACHEBCHELMNAKMT2A
SCHEMBL492856 0.85 SMN1; SMN2 (0.40) TDP1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL492543 0.84 FAAH (0.39) FAAHACHEBCHETDP1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD FAAH 6/4885ACHE 52/4885BCHE 3050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.